Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peiyuan Tongnao (PYTN) is a traditional Chinese medicine capsule formulation widely used for the treatment of cerebrovascular diseases, particularly cerebral infarction and ischemic stroke. It is composed of multiple herbal ingredients and is believed to exert neuroprotective effects by improving blood circulation in the brain and supporting recovery after stroke. The precise mechanisms of action are not fully elucidated but are thought to involve anti-inflammatory effects, antioxidative stress responses, inhibition of neuronal apoptosis, and improvement in microcirculation within cerebral tissues[1][2][3][4]. Clinical use focuses on aiding recovery from ischemic events such as stroke with symptoms like hemiplegia or tongue deviation[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on peiyuan tongnao.